Elbelt et al. (2009) studied insulin requirements in patients with T1DM and Addison’s disease treated with oral hydrocortisone or cortisone acetate divided into two or three doses per day, using either continuous subcutaneous insulin administration or conventional insulin injection therapy. This evidence concerns the gene INS and primary adrenal insufficiency.